REGRANEX

Drug Smith+Nephew, Inc.
Total Payments
$353,239
Transactions
12,705
Doctors
5,081
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $14,870 810 670
2023 $72,448 4,043 2,178
2022 $89,912 4,992 2,601
2021 $3,099 245 158
2020 $14,137 473 300
2019 $158,773 2,142 1,039

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $233,819 12,381 66.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $87,645 88 24.8%
Travel and Lodging $20,583 207 5.8%
Consulting Fee $10,455 12 3.0%
Space rental or facility fees (teaching hospital only) $600.00 1 0.2%
Education $115.00 15 0.0%
Gift $21.19 1 0.0%

Top Doctors Receiving Payments for REGRANEX

Doctor Specialty Location Total Records
, DPM Foot & Ankle Surgery Boynton Beach, FL $16,386 44
, MD Undersea and Hyperbaric Medicine Cheektowaga, NY $10,866 25
, D.P.M Podiatrist Bridgeport, CT $9,746 32
, DPM Podiatrist Cleveland, OH $9,572 21
, DPM Foot & Ankle Surgery Lexington, KY $8,986 30
, DPM Foot & Ankle Surgery Saint Louis, MO $8,714 44
, D.P.M Public Medicine Chicago, IL $7,023 19
, M.D Geriatric Medicine Dallas, TX $6,709 19
, DPM Foot & Ankle Surgery Toms River, NJ $6,610 18
, DPM Podiatrist Denton, TX $5,563 18
, DPM Podiatrist Houston, TX $5,340 18
, M.D Plastic Surgery Detroit, MI $4,198 9
, M.D Specialist Chattanooga, TN $3,730 17
, DPM Foot & Ankle Surgery Fort Collins, CO $3,189 5
, D.P.M Foot & Ankle Surgery Chevy Chase, MD $3,035 15
, DPM Podiatrist Burr Ridge, IL $2,754 31
, DPM Podiatrist Phildelphia, PA $1,862 14
, DPM Student in an Organized Health Care Education/Training Program Flushing, NY $1,203 7
, D.P.M Foot & Ankle Surgery Harrisburg, PA $1,200 1
, DPM Podiatrist Niles, OH $1,080 1
, MD Vascular Surgery New York, NY $1,012 14
, DPM Foot & Ankle Surgery Bronx, NY $936.17 4
, DPM Foot & Ankle Surgery North Miami Beach, FL $856.76 36
, M.D Plastic Surgery Peoria, AZ $795.02 2
Unknown Albuquerque, NM $781.35 10

About REGRANEX

REGRANEX is a drug associated with $353,239 in payments to 5,081 healthcare providers, recorded across 12,705 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..

Payment data is available from 2019 to 2024. In 2024, $14,870 was paid across 810 transactions to 670 doctors.

The most common payment nature for REGRANEX is "Food and Beverage" ($233,819, 66.2% of total).